Nephrology
Enhancing the understanding of rare renal diseases and accelerating the development of potential therapies.
Innovating in Nephrology
We are building on our expertise in rare nephrology to study, develop and advance a robust pipeline of investigational therapies across chronic and acute kidney diseases where the complement system may play a role.
Grounded in more than 30 years of rare disease research and development (R&D), we are exploring the potential to harness our understanding of the complement system to address the underlying cause of certain rare kidney disorders and slow disease progression – with the ultimate goal of preserving organ function.
By building on our leadership in rare disease R&D, progressing innovative trial designs and prioritising patient and caregiver perspectives, we strive to enhance the understanding of rare renal diseases, accelerate the development of additional, life-changing therapies and bring new hope to the global rare nephrology community.
Bone Metabolism
Researching and developing innovative treatments that aim to target the underlying causes of rare bone disorders.
Cardiology
Following the science to develop and evaluate potential innovative treatment options to help people living with rare cardiology conditions.
Endocrinology
Identifying potential new opportunities to advance care for those impacted by rare endocrine diseases.
Haematology
Working to improve potential outcomes for more people living with rare haematological diseases worldwide.
Neurology
Striving to advance scientific understanding in rare neurology and to accelerate the development of potential life-changing treatments.
Rare Cancers
Striving to advance scientific understanding of rare cancers to bring new solutions.
Veeva ID: GL/ALL/0031